TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends December 9, 1988